Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

14th International Myeloma Workshop /
Whole genome sequencing reveals underlying genetics of multiple myeloma

3rd - 7th Apr 2013

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.04.13
Views: 5796

Dr Jonathan Keats - The Translational Genomics Research Institute (TGen), Phoenix, USA

Dr Keats talks to ecancertv at the 14th International Multiple Myeloma Conference (IMW 2013) in Kyoto, Japan, 4th April 2013. Dr Keats and his team have been looking at the genomes of around 260 multiple myeloma patients from different studies to pull out key mutations and potential targets for new therapies.

In an ideal near future each multiple myeloma patient would have their whole genome sequence analysed so that targeted therapy can be administered.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation